CD109 nucleic acid molecules, polypeptides and methods of use
US7700316B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Inventors
Key dates
| Filing date | Mar 7, 2002 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | May 18, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention is a CD109 nucleic acid molecule and its corresponding polypeptide. The invention also includes biologically functional equivalent nucleic acid molecules and polypeptides. The invention also relates to methods of using these nucleic acid sequences and polypeptides in medical diagnosis and treatment and in drug screening.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.